U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 05:12:06 GMT 2023
Edited
by admin
on Sat Dec 16 05:12:06 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin CHIMERIC/HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
W984C353CG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEPATUXIZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 LIGHT CHAIN, DIMER
Common Name English
Depatuxizumab [WHO-DD]
Common Name English
ABT-806
Code English
ANTI-EGFR MAB ABT-806
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, ERBB1, HER1, HER-1, ERBB)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY GAMMA1 HEAVY CHAIN HUMANIZED (1-446) (HUMANIZED VH (HOMO S
Systematic Name English
depatuxizumab [INN]
Common Name English
ANTI-EGFR MOAB ABT-806
Common Name English
ANTI-EGFR MONOCLONAL ANTIBODY ABT-806
Common Name English
DEPATUXIZUMAB [USAN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 361811
Created by admin on Sat Dec 16 05:12:06 GMT 2023 , Edited by admin on Sat Dec 16 05:12:06 GMT 2023
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 05:12:06 GMT 2023 , Edited by admin on Sat Dec 16 05:12:06 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C95206
Created by admin on Sat Dec 16 05:12:06 GMT 2023 , Edited by admin on Sat Dec 16 05:12:06 GMT 2023
PRIMARY
USAN
CD-13
Created by admin on Sat Dec 16 05:12:06 GMT 2023 , Edited by admin on Sat Dec 16 05:12:06 GMT 2023
PRIMARY
DRUG BANK
DB12826
Created by admin on Sat Dec 16 05:12:06 GMT 2023 , Edited by admin on Sat Dec 16 05:12:06 GMT 2023
PRIMARY
ChEMBL
CHEMBL3707294
Created by admin on Sat Dec 16 05:12:06 GMT 2023 , Edited by admin on Sat Dec 16 05:12:06 GMT 2023
PRIMARY
CAS
1471999-69-5
Created by admin on Sat Dec 16 05:12:06 GMT 2023 , Edited by admin on Sat Dec 16 05:12:06 GMT 2023
PRIMARY
FDA UNII
W984C353CG
Created by admin on Sat Dec 16 05:12:06 GMT 2023 , Edited by admin on Sat Dec 16 05:12:06 GMT 2023
PRIMARY
INN
10262
Created by admin on Sat Dec 16 05:12:06 GMT 2023 , Edited by admin on Sat Dec 16 05:12:06 GMT 2023
PRIMARY
From To
1_22 1_96
1_143 1_199
1_219 3_214
1_225 2_225
1_228 2_228
1_260 1_320
1_366 1_424
2_22 2_96
2_143 2_199
2_219 4_214
2_260 2_320
2_366 2_424
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_296
N 2_296
Related Record Type Details
DEPATUXIZUMAB MAFODOTIN
CONJUGATE->CONJUGATE COMPONENT
EPIDERMAL GROWTH FACTOR RECEPTOR
TARGET -> INHIBITOR
ABT-806I
CONJUGATE->CONJUGATE COMPONENT
Related Record Type Details
DEPATUXIZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:CALCULATED CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966